66 reports

Cancer Immunotherapy Market is expected to witness a CAGR of 12.2% during the forecast period. Certain factors that are driving the market growth include rising R&D activities, increasing effectivity and accuracy of newer therapies, growing prevalence of cancer. The incidence of cancer is increasing significantly and has been the major...

  • Cancer
  • Cancer Immunotherapy
  • Therapy
  • Pharmaceutical
  • Cancer Incidence
  • Cancer Mortality

Cancer Immunotherapy market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Cancer Immunotherapy Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Cancer Immunotherapy types, applications. Further, Cancer...

  • Cancer Immunotherapy
  • World

Global Cancer Immunotherapy Market 2022-2026 The analyst has been monitoring the cancer immunotherapy market and it is poised to grow by $ 74.45 bn during 2022-2026, progressing at a CAGR of 14.67% during the forecast period. Our report on the cancer immunotherapy market provides a holistic analysis, market size and forecast,...

  • Cancer Immunotherapy
  • World

Abstract: - Global Cancer Immunotherapy Market to Reach $123.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cancer Immunotherapy estimated at US$70.9 Billion in the year 2020, is projected to reach a revised size of US$123.9 Billion by 2027, growing at a CAGR of 8.3% over the analysis period 2020-2027....

  • Cancer Immunotherapy
  • World
  • China
  • United States

The global cancer immunotherapy market reached a value of US$ 96.6 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 167.5 Billion by 2027 exhibiting a CAGR of 9.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...

  • Cancer Immunotherapy
  • World

Cancer Immunotherapy Market Report Overview Cancer Immunotherapy market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Cancer Immunotherapy market types and applications. It is a focused study on Cancer Immunotherapy market space including...

  • Cancer Immunotherapy
  • World
  • Health Provider Density

Abstract: - Global Cancer Immunotherapy Drug Discovery Outsourcing Market to Reach $2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cancer Immunotherapy Drug Discovery Outsourcing estimated at US$879.3 Million in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing...

  • Cancer Immunotherapy
  • World
  • China
  • United States

Antibody Drug Conjugates (ADCs), Bispecific Monoclonal  Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric  Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors,  Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT)  & IDO Inhibitors  Within...

  • Cancer Immunotherapy
  • Immunotherapy
  • Therapy
  • World

"Global Cancer Immunotherapy Market Opportunity, Dosage, Price & Clinical Trials Insight 2026" Report Highlights: • Global Cancer Immunotherapy Market Opportunity: > US$ 200 Billion  • Cancer Immunotherapy Clinical Trials: > 2300 Drugs In Trials • Commercially Available Cancer Immunotherapies: >...

  • Cancer Immunotherapy
  • World

Within the cancer therapeutics space, which today is worth over $100 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that have high specificity for cancer cells. Today, cancer immunotherapy drugs have captured nearly 50% of the overall oncology drugs market, generating...

  • Cancer Immunotherapy
  • World

The Global Cancer Vaccine Partnering Terms and Agreements 2010-2022 report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer vaccine partnering deals Disclosed headlines, upfronts, milestones and royalties...

  • Cancer Immunotherapy
  • World

Immune Checkpoint Inhibitors Market by Type (PD-1 Inhibitors, PD-L1 Inhibitors and CTLA-4 Inhibitor) and Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin lymphoma and other application): Global Opportunity Analysis and Industry Forecast, 2021-2030 The global immune checkpoint inhibitors market was...

  • Cancer
  • Cancer Immunotherapy
  • Immunotherapy
  • World
  • APAC

“Global Peptide Cancer Vaccine Market & Clinical Trials Insight 2026” Report Highlights: • Global Peptide Cancer Vaccine Market Trends Insight • Global Peptide Cancer Drugs Market Opportunity: >USD 20 Billion • Global Peptide Cancer Vaccine Clinical Trials Insight By Company, Indication & Phase • Number Of Peptide...

  • Cancer Immunotherapy
  • World
  • Mortality Rate

Global CTLA4 (Cytotoxic T-Lymphocyte-Alymphocyte-associated Protein 4) Inhibitors Market: About this market This CTLA4 (Cytotoxic T-Lymphocyte-Alymphocyte-associated Protein 4) inhibitors market analysis considers sales from both monotherapy and combination therapy . Our analysis also considers the sales of CTLA4 (Cytotoxic...

  • Cancer Immunotherapy
  • Immunotherapy
  • Lung Cancer
  • World

Global Neoantigen Cancer Vaccine Market to Reach $1,988.5 Million by 2031 Market Report Coverage - Neoantigen Cancer Vaccine Market Segmentation • Product Type - Personalized and Off-the-Shelf • Type of Neovaccine - Nucleic Acid Vaccine, Peptide Vaccine, and Dendritic Cell-Based Vaccine •...

  • Cancer Immunotherapy
  • World
  • APAC

Summary Clinical Laserthermia Systems AB (CLS) is a medical equipment company that develops and markets instruments for the treatment of cancer.The company offers Tranberg, a thermal therapy system developed for image guided high precision treatment of soft tissues and ablation procedures. Tranberg is approved in...

  • Prostate Cancer
  • Clinical Trial
  • Cancer Immunotherapy
  • World
  • Europe
  • United States
  • North America
  • Medical Devices Sales
  • Life Expectancy

Cancer Immunotherapy Market Analysis Report By Product (Oncolytic Viral Therapies & Cancer Vaccines, Monoclonal Antibodies, Immunomodulators), By Cancer Type (Breast, Lung), and Segment Forecasts, 2019 - 2026 The global cancer immunotherapy market size is likely to reach USD 126.9 billion by 2026, exhibiting a CAGR...

  • Cancer
  • Cancer Immunotherapy
  • Monoclonal Antibody
  • World
  • Cancer Incidence

Global Cancer Immunotherapy Market to Reach $170.70 billion by 2028 The healthcare industry is a multi-billion-dollar market consisting of various verticals aimed at improving patient lives.The industry has experienced considerable advancement in terms of diagnosis and treatment, yet cancer remains as one of the leading...

  • Oncology
  • Cancer Immunotherapy
  • Cancer
  • World

Report Scope: Finding the right career path is one of the biggest challenges in every person’s life.We want to make sure we make the right choices and decisions concerning our future employment opportunities. And it’s no longer a one-time decision. Employment conditions and opportunities are not constantly evolving...

  • Immunotherapy
  • Monoclonal Antibody
  • Drug Development
  • Biotechnology
  • Cancer Immunotherapy
  • World

Monoclonal Antibodies, Cytokines & Immunomodulators, Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy, Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Hospitals, Cancer Research Centres, Clinics The world cancer immunotherapy market is expected to...

  • Cancer Immunotherapy
  • World
  • APAC

Global Neoantigen Cancer Vaccine Market is Projected to Reach $1826.1 Million by 2030 Key Questions Answered in this Report: • What are the major market drivers, challenges, and opportunities in the global neoantigen cancer vaccine market? • What are the underlying structures resulting in the...

  • Cancer Immunotherapy
  • World

This study covers the world outlook for cancer immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Cancer Immunotherapy
  • World
  • Gross Domestic Product
  • Disposable Income

Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis Report By Drug, By Service, By Cancer Type (Lung, Breast, Colorectal, Melanoma, Prostate, Pancreatic), And Segment Forecasts, 2018 - 2025 The global cancer immunotherapy drug discovery outsourcing market size is projected to reach USD 1.7Billion by 2025,...

  • Cancer Immunotherapy
  • World
  • Cancer Incidence

The Global Cancer Immunotherapy Market size is expected to reach $128.3 billion by 2024, rising at a market growth of 14.3% CAGR during the forecast period. Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody,...

  • Cancer Immunotherapy
  • World
  • APAC
  • Health Expenditure

This report offers an eight year forecast on the global immune repertoire sequencing market. The primary objective of the report is to offer updates and information related to the opportunities in the immune repertoire sequencing market. Report Description In terms of revenue, the global immune repertoire sequencing...

  • Pharmaceutical
  • Genome Sequencing
  • Cancer Immunotherapy
  • Research Center
  • Diagnostics
  • World

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline Summary Cancer immunotherapy, which can predominantly be classed as a form of targeted therapy, drives an immune response against cancer cells. This...

  • Cancer Immunotherapy
  • World

The Europe Cancer Immunotherapy Market would witness market growth of 13.5 % CAGR during the forecast period (2018 – 2024). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines, checkpoint...

  • Cancer Immunotherapy
  • Europe
  • World
  • Health Expenditure

The Asia Pacific Market would witness market growth of 16.5% CAGR during the forecast period (2018 – 2024). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines, checkpoint inhibitors,...

  • Cancer Immunotherapy
  • APAC
  • Health Expenditure

The Latin America, Middle East and Africa Cancer Immunotherapy Market would witness market growth of 15.5% CAGR during the forecast period (2018 – 2024). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic...

  • Cancer Immunotherapy
  • World
  • Middle East
  • Latin America
  • Africa
  • Health Expenditure

The North America Cancer Immunotherapy Market would witness market growth of 13.1% CAGR during the forecast period (2018 – 2024). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines,...

  • Cancer Immunotherapy
  • North America
  • World
  • Health Expenditure